Your 10-Second Option
You know your patient. You know their risks. You know how long they have.
Now you have an alternative to central venous line placement in critical cases that don’t allow time for the recommended preparation and protocol. For these situations, there’s EZ-IO.
You Win
Central lines can take 11-25 minutes I, even without maximal sterile barrier precautions. EZ-IO means safe intraosseous (IO) access, usually within 10 seconds – providing a bridge until a necessary central line can be placed, or an alternative when long-term central lines are not absolutely necessary. Furthermore, central line infections are often caused by lack of adherence to protocol due to the patient’s urgent condition. EZ-IO means reduced risk and complications, and a fast, safe, easy-to-use addition to your team II.
I Paxton J, Knuth T, Klausner H. Humeral head intraosseous insertion: The preferred emergency venous access. Ann Emerg Med. 2008;52:S58.
II Published literature includes 16 clinical studies, 2938 patients, zero serious complications with the EZ-IO. To request a complete bibliography of published studies, contact us at cvl@vidacare.com.
Your Hospital Wins
Reducing risk is top priority for today’s hospitals, and risk of infection with central lines, particularly femoral lines, is a big reason to consider the EZ-IO alternative. Cost is another. The Centers for Medicare and Medicaid Services (CMS) and many major insurers no longer reimburse hospitals for most central line complications. Your clinician’s ability to place central lines safely – using IO as a bridge – can directly improve the economic health of your hospital. EZ-IO also means lower operational costs, lower use of costly central line catheters, less time and resources, including freeing up bed space more rapidly.
Your Patient Wins
Your patient’s well-being is your foremost concern. With EZ-IO as a new option, patients have the benefit of immediate vascular access that can prevent their deterioration and move them to the next phase of care rapidly. EZ-IO also provides much less exposure to complication risks. These are reasons why early use of IO is endorsed by the American Heart Association (AHA), the European Resuscitation Council (ERC), the International Liaison Committee on Resuscitation (ILCOR), and the Infusion Nurses Society.
